Back
Design Therapeutics Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
DSGN
Design Therapeutics
Last Price:
$4.64
Seasonality Move:
-0.72%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder that's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Design Therapeutics Stock Forecast
-
Is Design Therapeutics Stock Undervalued?The current Design Therapeutics [DSGN] share price is $4.64. The Score for DSGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
DSGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Design Therapeutics Stock Go Up Next Year?
Data Unavailable
Design Therapeutics Stock Rating
Data Unavailable
Design Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
designtx.com
52-Week Data
52-Week High:
7.77
52-Week Low:
2.91
Prediction Charts
Market Cap:
263.4M
Price in USD:
4.64
Volume:
102.4K
Beta:
1.79
Technical Analysis
SMA50:
4.80
SMA100:
5.39
SMA200:
4.97
52-Wk Change:
60%
Stock Predictions
-
Is Design Therapeutics stock public?Yes, Design Therapeutics is a publicly traded company.
-
What is the Design Therapeutics stock quote today?The Design Therapeutics stock price is 4.64 USD today.
-
How to buy Design Therapeutics stock online?You can buy Design Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-28 | 4.63 | 4.86 | 4.89 | 4.61 |
| Mar-3 | 4.87 | 4.50 | 4.97 | 4.44 |
| Mar-4 | 4.41 | 5.05 | 5.10 | 4.04 |
| Mar-5 | 4.98 | 4.94 | 5.10 | 4.73 |
| Mar-6 | 4.81 | 5.12 | 5.36 | 4.73 |
| Mar-7 | 5.12 | 4.92 | 5.18 | 4.88 |
| Mar-11 | 4.87 | 5.33 | 5.42 | 4.82 |
| Mar-12 | 5.36 | 4.96 | 5.57 | 4.89 |
| Mar-13 | 4.94 | 4.72 | 4.94 | 4.59 |
| Mar-14 | 4.83 | 4.71 | 4.95 | 4.70 |
| Mar-17 | 4.70 | 4.93 | 5.04 | 4.65 |
| Mar-18 | 4.95 | 4.81 | 5.12 | 4.67 |
| Mar-19 | 4.80 | 4.83 | 4.94 | 4.58 |
| Mar-20 | 4.79 | 4.64 | 4.95 | 4.60 |
Design Therapeutics Earnings
Data Unavailable
Design Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.31 per share, and an increase next year of $0.09 per share.
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.